Kiora Pharmaceuticals, Inc. Common Stock
KPRX
KPRX: Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. It operates in one reportable segment operations and manages.
moreShow KPRX Financials
Recent trades of KPRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by KPRX's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Compounds for treating ophthalmic diseases and disorders Aug. 22, 2023
-
Patent Title: Compositions and methods for treatment of ocular diseases Jul. 05, 2022
Federal grants, loans, and purchases
Followers on KPRX's company Twitter account
Number of mentions of KPRX in WallStreetBets Daily Discussion
Recent insights relating to KPRX
Recent picks made for KPRX stock on CNBC
ETFs with the largest estimated holdings in KPRX
Flights by private jets registered to KPRX